Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational studyEli Muchtar, Hila Magen, Chezi Ganzel et al.|British Journal of Haematology|2015Cited by 38
Outcomes of light‐chain amyloidosis patients treated with first‐line bortezomib: a collaborative retrospective multicenter assessmentMoshe E. Gatt, Izhar Hardan, Evgeni Chubar et al.|European Journal Of Haematology|2015Cited by 16